Merck & Co., Inc. (MRK) operating KPIs
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)
Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%
Merck de Minimis Excluded Non-U.S. Employees in CEO Pay Ratio (headcount)
DEF 14A Pay Ratio
Latest, FY2025
3,996
Period ended Dec 31, 2025
Change on a year earlier
+1.5%
3,938 in FY2024
History
7 years
Since FY2019
Sources
7
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | De Minimis Excluded Non-U.S. Employees in CEO Pay Ratio (headcount) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3,996 | +1.5% | DEF 14A (d85708ddef14a.htm, filed 2026-04-08) ↗ |
| FY2024 | Dec 31, 2024 | 3,938 | +3.4% | DEF 14A (d151723ddef14a.htm, filed 2025-04-09) ↗ |
| FY2023 | Dec 31, 2023 | 3,810 | +4.2% | DEF 14A (d500367ddef14a.htm, filed 2024-04-11) ↗ |
| FY2022 | Dec 31, 2022 | 3,656 | +1.6% | DEF 14A (d277607ddef14a.htm, filed 2023-04-03) ↗ |
| FY2021 | Dec 31, 2021 | 3,600 | -7.2% | DEF 14A (d154286ddef14a.htm, filed 2022-04-04) ↗ |
| FY2020 | Dec 31, 2020 | 3,881 | +4.8% | DEF 14A (d50486ddef14a.htm, filed 2021-04-05) ↗ |
| FY2019 | Dec 31, 2019 | 3,703 | – | DEF 14A (d766375ddef14a.htm, filed 2020-04-06) ↗ |
Cite this data
StockData. (2026). Merck De Minimis Excluded Non-U.S. Employees in CEO Pay Ratio (headcount), annual FY2019–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/hr_emp_excl
See every metric in the Merck KPI table. Data updated Oct 26, 2026.